Table: begin end state 1 29 cytoplasmic 30 48 transmembrane 49 53 non-cytoplasmic 54 72 transmembrane 73 102 cytoplasmic 103 124 transmembrane 125 142 non-cytoplasmic 143 161 transmembrane 162 171 cytoplasmic 172 192 transmembrane 193 211 non-cytoplasmic 212 234 transmembrane 235 254 cytoplasmic 255 277 transmembrane 278 300 non-cytoplasmic 301 323 transmembrane 324 344 cytoplasmic 345 362 transmembrane 363 366 non-cytoplasmic 367 391 transmembrane 392 403 cytoplasmic 404 425 transmembrane 426 426 non-cytoplasmic
Input: >Pf6N2E2_563 FitnessBrowser__pseudo6_N2E2:Pf6N2E2_563 MNDQANSVEERFETTVPATLSQWSRQDTTWMLGLFGTAIGAGTLFLPINAGLGGFWPLLI LAVLAFPMTFYAHRGLTRFVLSGRDGADITEVVEEHFGLKAGALITLLYFFAIFPILLIY SVALTNTVGSFLEHQLHIQPPPRAVLSLMLILGLLAVVRCGEQAIVKAMSLMVYPFIVAL LFLAVFLIPHWSGGILTTASTPPEPSALLHTLWLAIPVMVFSFNHSPIISAFAVDQKRRY GANAEERSSQILSRAHVLMVVMVLFFVFSCVLTLSPAQLAEAKAQNLSILSYLANHFSNP TIAFAAPLIAFVAISKSFLGHYIGASEGLKGLIVKSGRRPAPKTLDRLTAAFMLVVCWIV ATLNPSILGMIETLGGPVIAAILFLMPMYAIRKVPAMARYRGQASNVFVVLVGLVAITAL VYSLIA
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server